Related Experiment Video
Updated: Jan 23, 2026
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Immune response in RSV bronchiolitis: The key to more effective therapeutic interventions
Iolanda Jordan1, Mònica Balaguer1
1Pediatric Intensive Care Unit, Hospital Sant Joan de Deu, University of Barcelona, Barcelona, Spain.
Insights
Respiratory syncytial virus (RSV) causes bronchiolitis, a severe childhood illness. Understanding the immune response is key to developing targeted treatments for this common viral infection.
Area of Science:
- Immunology
- Virology
- Pediatrics
Background:
- Respiratory syncytial virus (RSV) is a leading cause of bronchiolitis in children.
- Hospitalized children with RSV bronchiolitis have a 1-3% mortality rate.
- Disease severity is closely linked to the host's immune response.
Purpose of the Study:
- To review the immunological mechanisms underlying RSV bronchiolitis.
- To correlate specific treatments with their corresponding immunological responses.
- To highlight the importance of immunologically targeted therapies for RSV bronchiolitis.
Main Methods:
- Review of existing literature on RSV immunology.
- Analysis of intracellular signaling pathways activated by RSV via Toll-like receptors.
- Examination of the Th1/Th2 immune response balance regulated by gamma interferon.
Main Results:
- RSV infection triggers intracellular signaling in respiratory epithelial cells.
- Primary RSV infection elicits a mixed Th1/Th2 immune response.
- An overactive Th2 response is associated with increased disease severity.
Conclusions:
- Targeted immunological treatments are crucial for managing RSV bronchiolitis.
- Understanding the immune response is essential for effective therapeutic strategies.
- Further research into immune modulation may improve outcomes for children with RSV bronchiolitis.
Abstract:
Respiratory syncytial virus (RSV) is among the primary pathogens of bronchiolitis. The mortality rate among hospitalized children with RSV bronchiolitis is approximately 1 to 3%. As reported by various authors, the severity of this viral disease is linked to immune response. Thus, it is important that treatment for RSV bronchiolitis be immunologically targeted. The virus activates intracellular signaling in respiratory epithelial cells via receptors known as Toll-like receptors. After this stimulation, primary RSV infection generates a mixed Th1/Th2 response, which is regulated by gamma interferon. An exacerbated Th2 response would lead to a more severe infection. Herein we review the immunologic mechanisms behind RSV bronchiolitis in order to correlate each treatment with a corresponding immunological response.
More Related Videos
09:01An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
06:09Wheel Running and Environmental Complexity as a Therapeutic Intervention in an Animal Model of FASD
Published on: February 2, 2017
Related Concept Videos
01:36Humoral Immune Responses
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
01:40Cell-mediated Immune Responses
01:23Cells of the Adaptive Immune Response
01:29Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
01:28Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...